-
Mashup Score: 4Subcutaneous Mosunetuzumab Demonstrates Encouraging Efficacy, Manageable Safety as Frontline Therapy for High-Tumor Burden Follicular Lymphoma - 1 month(s) ago
At the 65th ASH Annual Meeting, Lorenzo Falchi, MD, shares results which indicated that subcutaneous mosunetuzumab as first-line therapy demonstrated efficacious outcomes and manageable safety among patients with high-tumor burden FL.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FLASH Study Finds Mechanical Thrombectomy Significantly Improves Patient Outcomes and Quality of Life Following a Pulmonary Embolism - 11 month(s) ago
May 24, 2023 — The largest interventional study focused on pulmonary embolisms highlighted importance of rapid removal of blood clots for immediate and longer-term patient benefit during a recent conference which gathered interventional cardiologists from around the world. Six-month outcomes from the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) registry study were…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor Six-month outcomes from the #FlowTriever All-Comer Registry for Patient Safety and #Hemodynamics (#FLASH) registry were presented at #scai23: https://t.co/4HVCN0ARGR
-
-
Mashup Score: 2Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers recently investigated the efficacy and safety of topical synthetic hypericin for the treatment of cutaneous T-cell #lymphoma in the Phase III clinical trial called #FLASH: https://t.co/c2R8c31IkP #CTCL #HemOnc https://t.co/ClvmYWJhhg
-
-
Mashup Score: 2Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers recently investigated the efficacy and safety of topical synthetic hypericin for the treatment of cutaneous T-cell #lymphoma in the Phase III clinical trial called #FLASH: https://t.co/c2R8c3jjcn #CTCL #HemOnc https://t.co/Wt110Gy4rS
-
-
Mashup Score: 4Clinical Application of FLASH Radiation Therapy - 2 year(s) ago
Wednesday, September 21, 2022 at 2:00 PM Eastern Daylight Time.
Source: event.on24.comCategories: Latest Headlines, Oncologists2Tweet-
RT @Applied_RadOnc: [WEBINAR Tomorrow] Clinical Application of #FLASH Radiation Therapy Webinar | Register ⏩https://t.co/crLZAxhX4x #RadOn…
-
-
Mashup Score: 1FLASH for Doctors - WSLHD - 2 year(s) ago
Applications close on 29th April 2022 All doctors need to be effective leaders within our health systems for optimal patient care. This 7-month practical program will improve your confidence and performance in all the areas of leadership required and/or chosen throughout your career. Being a leader is…
Source: www.wslhd.health.nsw.gov.auCategories: Latest Headlines, Oncologists2Tweet-
APPLY NOW! #FLASH ‘Fostering Leaders Across Systems in Health’ #2 is open for early career medical leaders in Western Sydney @RENWestmead @WestSydHealth #leadership #Network #MedEd https://t.co/FLpCRqDD9A https://t.co/qtI5OCmybD
-
-
Mashup Score: 0Constantinos Koumenis, PhD @PennMedicine #FLASH #Radiat - 2 year(s) ago
Constantinos Koumenis, Ph.D., BS, Richard H. Chamberlain Professor of Research Oncology, Department of Radiation Oncology, Perelman School of Medicine, Uni
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
High-Dose FLASH Study Constantinos Koumenis, PhD @PennMedicine #FLASH #Radiation https://t.co/JehZF8Eb57 https://t.co/nRnyrDMLn2
-
-
Mashup Score: 1Podcast Constantinos Koumenis, PhD @PennMedicine #FLASH - 2 year(s) ago
Constantinos Koumenis, Ph.D., BS, Richard H. Chamberlain Professor of Research Oncology, Department of Radiation Oncology, Perelman School of Medicine, Uni
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Podcast - High-Dose FLASH Study Constantinos Koumenis, PhD @PennMedicine #FLASH #Radiation Link to Audio: https://t.co/1ktdhuRmZr https://t.co/wx4tpBFput
-
-
Mashup Score: 0PowerStore Scalable All-Flash Storage - 2 year(s) ago
PowerStore all-flash storage eliminates tradeoffs in performance, scalability, and storage efficiency, with a data-centric infrastructure.
Source: www.delltechnologies.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
See the capabilities of @DellEMC #PowerStore in their #virtuallab. The groundbreaking #PowerStore family of #flash #datastorage appliances transforms traditional and modern workloads with a data-centric, intelligent, and adaptable infrastructure. https://t.co/eCaEnzAbjL #CIO https://t.co/HESzcjXKcz
-
-
Mashup Score: 1PowerStore Scalable All-Flash Storage - 2 year(s) ago
PowerStore all-flash storage eliminates tradeoffs in performance, scalability, and storage efficiency, with a data-centric infrastructure.
Source: www.delltechnologies.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
See the capabilities of @DellEMC #PowerStore in their #virtuallab. The groundbreaking #PowerStore family of #flash #datastorage appliances transforms traditional and modern workloads with a data-centric, intelligent, and adaptable infrastructure. https://t.co/eCaEnzAbjL https://t.co/BjQsmAlyfa
-
Lorenzo Falchi, MD, @MSKCancerCenter, discusses subcutaneous mosunetuzumab as first-line therapy, which showed high efficacy and safety among patients with high-tumor burden #FL, including those with high-risk disease. Learn more: https://t.co/nWbX3HJBzi @falchi_lorenzo #ASH https://t.co/bZBsoREL3f